Physician profile
Rakesh Devendrakumar Patel
NPI 1821574468
$627.68
in general payments reported to CMS, 2019-2025
20 companies · $56.23 in 2025
The $56.23 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $432 · 2023: $31.72 · 2024: $108 · 2025: $56.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $125.37 | 2023-2024 | |
| Amgen INC. | $52.71 | 2021 | |
| Amneal Pharmaceuticals LLC | $42.03 | 2021-2025 | Crexont |
| Merck Sharp & Dohme LLC | $40.59 | 2021 | |
| Abbvie INC. | $35.04 | 2021 | |
| Lundbeck LLC | $34.23 | 2025 | Vyepti |
| Sunovion Pharmaceuticals INC. | $28.87 | 2021 | |
| Ucb, INC. | $26.01 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $24.91 | 2021 | |
| Supernus Pharmaceuticals, INC. | $24.77 | 2021 | |
| Lilly USA, LLC | $24.62 | 2021 | |
| Genzyme Corporation | $23.67 | 2021 | |
| Greenwich Biosciences, INC. | $22.29 | 2021 | |
| Genentech USA, INC. | $22.20 | 2021 | |
| Neurocrine Biosciences, INC. | $20.92 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $19.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.09 | 2021 | |
| Emd Serono, INC. | $16.69 | 2021 | |
| Mdd US Operations, LLC | $14.33 | 2024 | Apokyn |
| Upsher-Smith Laboratories LLC | $11.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rakesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.